Evidence map›Paper›PMID 27612989›Full record

ArticleHaematologica2017

Distinct global binding patterns of the Wilms tumor gene 1 (WT1) -KTS and +KTS isoforms in leukemic cells.

Tove Ullmark, Linnea Järvstråt, Carl Sandén, Giorgia Montano, Helena Jernmark-Nilsson, Henrik Lilljebjörn, Andreas Lennartsson, Thoas Fioretos, Kristina Drott, Karina Vidovic and 2 more

Open access · goldAbstract read
In one paragraph

Article in Haematologica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Targeting alternative splicing in cancer immunotherapy.Frontiers in cell and developmental biology · 2023
    Review
  6. A NovelBiology · 2021
    Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Tove UllmarkDivision of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Huddinge, Sweden.
Linnea JärvstråtDivision of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Huddinge, Sweden.
Carl SandénDivision of Clinical Genetics, Department of Laboratory Medicine, Lund University, Huddinge, Sweden.
Giorgia MontanoDivision of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Huddinge, Sweden.
Helena Jernmark-NilssonDivision of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Huddinge, Sweden.
Henrik LilljebjörnDivision of Clinical Genetics, Department of Laboratory Medicine, Lund University, Huddinge, Sweden.
Andreas LennartssonDepartment of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.
Thoas FioretosDivision of Clinical Genetics, Department of Laboratory Medicine, Lund University, Huddinge, Sweden.
Kristina DrottDivision of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Huddinge, Sweden.
Karina VidovicDivision of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Huddinge, Sweden.
Björn NilssonDivision of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Huddinge, Sweden.
Urban GullbergDivision of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Huddinge, Sweden urban.gullberg@med.lu.se.
Lund University · SEKarolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The zinc finger transcription factor Wilms tumor gene 1 (WT1) acts as an oncogene in acute myeloid leukemia. A naturally occurring alternative splice event between zinc fingers three and four, removing or retaining three amino acids (±KTS), is believed to change the DNA binding affinity of WT1, although there are conflicting data regarding the binding affinity and motifs of the different isoforms. Increased expression of the WT1 -KTS isoform at the expense of the WT1 +KTS isoform is associated with poor prognosis in acute myeloid leukemia. We determined the genome-wide binding pattern of WT1 -KTS and WT1 +KTS in leukemic K562 cells by chromatin immunoprecipitation and deep sequencing. We discovered that the WT1 -KTS isoform predominantly binds close to transcription start sites and to enhancers, in a similar fashion to other transcription factors, whereas WT1 +KTS binding is enriched within gene bodies. We observed a significant overlap between WT1 -KTS and WT1 +KTS target genes, despite the binding sites being distinct. Motif discovery revealed distinct binding motifs for the isoforms, some of which have been previously reported as WT1 binding sites. Additional analyses showed that both WT1 -KTS and WT1 +KTS target genes are more likely to be transcribed than non-targets, and are involved in cell proliferation, cell death, and development. Our study provides evidence that WT1 -KTS and WT1 +KTS share target genes yet still bind distinct locations, indicating isoform-specific regulation in transcription of genes related to cell proliferation and differentiation, consistent with the involvement of WT1 in acute myeloid leukemia.

Indexed as

Alternative SplicingGene Expression Regulation, LeukemicBinding SitesChromatin ImmunoprecipitationHigh-Throughput Nucleotide SequencingHumansLeukemiaNucleotide MotifsProtein BindingTranscription FactorsTranscription Initiation SiteWT1 ProteinsTranscription FactorsWT1 Proteins

Identifiers

PMID27612989
PMCPMC5286941
OpenAlexW2515728885

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.